Systematic assessment of pharmaceutical prescriptions in association with cancer risk: a method to conduct a population-wide medication-wide longitudinal study
Authors:
Open Access
- 10 August 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 31308
Abstract
It is a public health priority to identify the adverse and non-adverse associations between pharmaceutical medications and cancer. We search for and evaluate associations between all prescribed medications and longitudinal cancer risk in participants of the Swedish Cancer Register (N = 9,014,975). We associated 552 different medications with incident cancer risk (any, breast, colon and prostate) during 5.5 years of follow-up (7/1/2005-12/31/2010) in two types of statistical models, time-to-event and case-crossover. After multiple hypotheses correction and replication, 141 (26%) drugs were associated with any cancer in a time-to-event analysis constraining drug exposure to 1 year before first cancer diagnosis and adjusting for history of medication use. In a case-crossover analysis, 36 drugs (7%) were associated with decreased cancer risk. 12 drugs were found in common in both analyses with concordant direction of association. We found 14, 10, 7% of all drugs associated with colon, prostate and breast cancers in time-to-event models. We only found 1, 2% and 0% for these cancers, respectively, in case-crossover analyses. Pharmacoepidemiologic analyses of cancer risk are sensitive to modeling choices and false-positive findings are a threat. Medication-wide analyses using different analytical models may help suggest consistent signals of increased cancer risk.Keywords
This publication has 24 references indexed in Scilit:
- Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination SurveyInternational Journal of Epidemiology, 2013
- High-dimensional, massive sample-size Cox proportional hazards regression for survival analysisBiostatistics, 2013
- Medication‐Wide Association StudiesCPT: Pharmacometrics & Systems Pharmacology, 2013
- Interpreting observational studies: why empirical calibration is needed to correct p‐valuesStatistics in Medicine, 2013
- A Nutrient-Wide Association Study on Blood PressureCirculation, 2012
- Novel Data-Mining Methodologies for Adverse Drug Event Discovery and AnalysisClinical Pharmacology & Therapeutics, 2012
- An Environment-Wide Association Study (EWAS) on Type 2 Diabetes MellitusPLOS ONE, 2010
- The Nordic Countries as a Cohort for Pharmacoepidemiological ResearchBasic & Clinical Pharmacology & Toxicology, 2010
- Why Most Published Research Findings Are FalsePLOS Medicine, 2005
- Triggering of Acute Myocardial Infarction by Heavy Physical Exertion -- Protection against Triggering by Regular ExertionNew England Journal of Medicine, 1993